We are live on ! Find out more
LCS

Levin Capital Strategies Portfolio holdings

AUM $1.49B
1-Year Est. Return 30.44%
This Fund
S&P 500
This Quarter Est. Return
+7.74%
1 Year Est. Return
+30.44%
3 Year Est. Return
+88.59%
5 Year Est. Return
+121.06%
10 Year Est. Return
+327.09%
AUM
$1B
AUM Growth
+$98.9M
Cap. Flow
+$35.6M
Cap. Flow %
3.55%
Top 10 Hldgs %
39.69%
Holding
237
New
32
Increased
42
Reduced
52
Closed
28

Top Sells

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$14.3M
2
CTVA icon
Corteva
CTVA
+$11.4M
3
EVH icon
Evolent Health
EVH
+$6.69M
4
MSFT icon
Microsoft
MSFT
+$5.77M
5
WAB icon
Wabtec
WAB
+$4.62M

Sector Composition

Rank Sector Weight
1 Financials 19.97%
2 Healthcare 14.34%
3 Technology 13.99%
4 Communication Services 10.15%
5 Energy 9.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BHVN
101
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$708K 0.07%
+13,000
New +$644K
GTYH
102
DELISTED
GTY Technology Holdings, Inc. Common Stock
GTYH
$669K 0.07%
113,604
SNDA icon
103
Sonida Senior Living
SNDA
$1.91B
$622K 0.06%
13,412
-14,260
-52% -$833K
ORLY icon
104
O'Reilly Automotive
ORLY
$68.9B
$606K 0.06%
20,730
FWONK icon
105
Liberty Media Series C
FWONK
$23.8B
$589K 0.06%
13,260
MNDT
106
DELISTED
Mandiant, Inc. Common Stock
MNDT
$579K 0.06%
35,000
+25,000
+250% +$401K
FNF icon
107
Fidelity National Financial
FNF
$11.7B
$577K 0.06%
13,224
VISN
108
Vistance Networks Inc
VISN
$1.55B
$568K 0.06%
40,000
-2,935
-7% -$38.1K
LBTYA icon
109
Liberty Global Class A
LBTYA
$3.58B
$542K 0.05%
23,840
VXX icon
110
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$132M
$529K 0.05%
547
+359
+191% +$434K
SLG icon
111
SL Green Realty
SLG
$3.67B
$520K 0.05%
5,842
+349
+6% +$28.7K
EMR icon
112
Emerson Electric
EMR
$82B
$519K 0.05%
6,811
GLRE icon
113
Greenlight Captial
GLRE
$493M
$505K 0.05%
50,000
+35,000
+233% +$362K
YEXT icon
114
Yext
YEXT
$632M
$505K 0.05%
+35,000
New +$543K
CRWD icon
115
CrowdStrike
CRWD
$248B
$499K 0.05%
+40,000
New +$525K
LAB icon
116
Standard BioTools
LAB
$271M
$493K 0.05%
141,588
-11,841
-8% -$41.7K
FPH icon
117
Five Point Holdings
FPH
$363M
$490K 0.05%
+70,500
New +$482K
INTC icon
118
Intel
INTC
$513B
$462K 0.05%
7,720
-1,228
-14% -$68.7K
DISCK
119
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$438K 0.04%
14,365
LAMR icon
120
Lamar Advertising Co
LAMR
$15B
$432K 0.04%
4,840
GRA
121
DELISTED
W.R. Grace & Co.
GRA
$427K 0.04%
6,115
-16,000
-72% -$1.07M
SLB icon
122
SLB Ltd
SLB
$80.4B
$409K 0.04%
10,184
GPC icon
123
Genuine Parts
GPC
$18.1B
$405K 0.04%
3,816
NVGS icon
124
Navigator Holdings
NVGS
$1.51B
$397K 0.04%
29,500
+5,000
+20% +$59.2K
WFC icon
125
Wells Fargo
WFC
$271B
$396K 0.04%
7,354

Similar funds

Levin Capital Strategies's Q4 2019 Portfolio in Review

As of Q4 2019, Levin Capital Strategies held 237 positions worth $1B, up 11% from $905M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Levin Capital Strategies deployed $35.6M of net new capital in Q4 2019, opening 32 new positions and adding to 42 existing holdings. Its largest new stake was Boeing: 29,174 shares worth $9.5M.

By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was DuPont de Nemours, an estimated $14.3M trimmed.

  • Levin Capital Strategies's largest Q4 2019 buy was Boeing: 29,174 shares worth $9.5M.
  • Levin Capital Strategies added most to Occidental Petroleum in Q4 2019, an estimated $22.2M increase.
  • Levin Capital Strategies's biggest Q4 2019 reduction was DuPont de Nemours, cutting an estimated $14.3M.
  • Levin Capital Strategies fully exited Quest Diagnostics in Q4 2019, selling an estimated $3.72M.
  • Levin Capital Strategies's ten largest holdings make up 40% of its $1B portfolio in Q4 2019.
  • Levin Capital Strategies opened 32 new positions and closed 28 in Q4 2019.
  • Levin Capital Strategies's portfolio value rose 11% quarter-over-quarter to $1B.

Based on Levin Capital Strategies's 13F filing for Q4 2019, filed 10 Feb 2020.